Introduction

Cardiac pacing has saved millions of lives since the first implantable pacemaker was introduced in the late 1950s. Over the decades, these devices have evolved from bulky external units to sophisticated implantable systems that regulate heart rhythm with precision. One of the most persistent challenges in pacemaker design has been power management. The battery that drives the device must be small, safe, reliable, and long-lasting, all while operating inside the human body under demanding physiological conditions. Recent advances in materials science, microelectronics, and energy harvesting are pushing pacemaker power systems into a new era. Engineers and clinicians are working together to develop batteries that last longer, charge faster, and eventually eliminate the need for surgical replacement entirely. This article examines the emerging trends in pacemaker battery technology and energy harvesting, highlighting the innovations that are reshaping cardiac care.

The Current Standard: Lithium-Based Batteries

For more than four decades, lithium-iodine batteries have served as the gold standard for implantable pacemakers. These cells offer a favorable balance of energy density, voltage stability, and long shelf life. A typical lithium-iodine pacemaker battery provides about 1 to 2 ampere-hours of capacity, which translates to five to fifteen years of device operation depending on pacing demand, device features, and patient factors such as heart rate and dependency level.

Lithium batteries used in pacemakers are not the same as the lithium-ion cells found in consumer electronics. Pacemaker batteries are designed for ultra-low discharge rates, extreme reliability, and hermetic sealing to prevent leakage of corrosive materials. The cathode in a lithium-iodine cell is a solid layer of iodine mixed with a polymer, while the anode is metallic lithium. A thin electrolyte layer of lithium iodide forms between them, allowing ionic conduction while electrically isolating the electrodes. This chemistry produces a steady voltage of about 2.8 volts and a gradual decline in capacity that gives clinicians ample warning before the battery is depleted.

Despite their reliability, lithium-iodine batteries have limitations. Their energy density is constrained by the solid-state chemistry, and internal resistance increases over time as the electrolyte layer thickens. Patients who are pacemaker-dependent may require device replacement every five to eight years, each procedure carrying risks of infection, bleeding, and mechanical complications. These limitations have motivated intensive research into next-generation power sources that can extend device longevity and reduce the burden of repeat surgeries.

Next-Generation Battery Technologies

Researchers are pursuing several promising battery chemistries and architectures that could significantly outperform current lithium-iodine cells. These include solid-state batteries, advanced lithium-ion variants, and biocompatible supercapacitors.

Solid-State Batteries

Solid-state batteries replace the liquid or gel electrolyte found in conventional cells with a solid ionic conductor. This design offers several advantages for implantable medical devices. Solid electrolytes are non-flammable and chemically stable, eliminating the risk of leakage or thermal runaway. They also allow the use of high-capacity lithium metal anodes, which can more than double the energy density compared to lithium-iodine chemistry.

Recent breakthroughs in solid electrolyte materials, such as lithium garnets (e.g., LLZO) and sulfide-based glasses, have brought solid-state pacemaker batteries closer to commercial viability. These materials exhibit high ionic conductivity at body temperature and remain stable over thousands of charge-discharge cycles. Companies like QuantumScape and Ilika have demonstrated solid-state cells that retain more than 90 percent of their initial capacity after 1,000 cycles, a level of durability that would support twenty to thirty years of pacemaker operation.

The miniaturization of solid-state batteries is another active area of research. Thin-film solid-state batteries, fabricated using sputtering or atomic layer deposition, can be made as small as a few square millimeters while still delivering sufficient power for pacing. These micro-batteries can be integrated directly onto the pacemaker circuit board, reducing device volume and enabling more complex multi-electrode pacing systems.

Advanced Lithium-Ion Variants

While standard lithium-ion cells are not commonly used in pacemakers due to safety concerns and limited cycle life at low discharge rates, new cathode and anode materials are changing that calculus. Lithium iron phosphate (LFP) cathodes offer exceptional thermal stability and a flat voltage profile, making them attractive for implantable applications. Paired with lithium titanate (LTO) anodes, LFP cells can achieve cycle lives exceeding 10,000 cycles with minimal capacity fade.

Another variant is the lithium carbon monofluoride (Li/CFx) chemistry, which combines high energy density with a gradual discharge curve similar to lithium-iodine. Li/CFx cells can store up to 800 watthours per kilogram, more than double that of conventional lithium-iodine batteries. Researchers have demonstrated prototype pacemaker batteries using Li/CFx chemistry that maintain stable voltage output for more than fifteen years of simulated pacing. These cells are now undergoing preclinical safety testing, and several manufacturers expect to bring them to market within the next few years.

Biocompatible Supercapacitors

Supercapacitors store energy electrostatically rather than chemically, allowing them to deliver high power in short bursts and to endure millions of charge-discharge cycles without degradation. For pacemakers, supercapacitors can serve as a complement to batteries, handling the high-current demands of pacing pulses while the battery supplies average power over longer periods. Recent advances in carbon nanotube and graphene electrodes have produced supercapacitors with energy densities approaching those of thin-film batteries, along with the ability to charge in seconds.

Researchers at the University of California San Diego have developed a flexible supercapacitor made from biocompatible materials that can be implanted alongside a pacemaker. The device charges wirelessly from an external transmitter and can deliver pacing pulses for several minutes without a battery. This technology is still in the research phase, but it points toward a future in which pacemakers operate for extended periods without primary batteries.

Energy Harvesting: Powering Devices from the Body

Energy harvesting captures ambient energy from the body or the environment and converts it into electrical power. For pacemakers, harvesting techniques aim to reduce or eliminate dependence on primary batteries, making devices self-sustaining and eliminating the need for replacement surgeries. The human body offers several energy sources: mechanical motion (heartbeat, blood flow, muscle movement), thermal gradients (body heat relative to ambient temperature), and chemical energy (glucose oxidation). Each requires a transducer optimized for the low power levels available inside the body.

Piezoelectric Energy Harvesting

Piezoelectric materials generate an electric charge when mechanically strained. By attaching a piezoelectric cantilever or membrane to the heart wall or a major blood vessel, researchers can convert the rhythmic contractions of the cardiac cycle into usable electrical energy. The typical power output from a cardiac piezoelectric harvester ranges from 1 to 20 microwatts, which is sufficient to power a modern pacemaker operating at a low duty cycle.

A landmark study published in 2023 demonstrated a flexible piezoelectric device based on lead zirconate titanate (PZT) nanofibers embedded in a polymer matrix. When implanted on the surface of a porcine heart, the device generated an average power of 8.4 microwatts, enough to keep a pacemaker running continuously. The device remained functional for more than 8 million cycles without fatigue, indicating excellent durability. Researchers at the University of Toronto have since developed a biocompatible piezoelectric harvester using zinc oxide nanowires, which avoids the lead content of PZT and improves long-term safety.

Piezoelectric harvesting faces several challenges. The power output depends strongly on the mechanical coupling between the harvester and the moving tissue, and any degradation in adhesion can reduce efficiency. Additionally, the harvester must be encapsulated to prevent immune rejection while still allowing mechanical deflection. Despite these hurdles, clinical trials of piezoelectric pacemakers are expected to begin within five years.

Thermal Energy Harvesting

Thermoelectric generators (TEGs) convert heat flow into electricity using the Seebeck effect. In the human body, a small temperature difference exists between the core (37 °C) and the skin surface (typically 28–34 °C depending on ambient conditions). By placing a TEG in thermal contact with both a warm internal organ and a cooler subcutaneous layer, researchers can harvest a few microwatts of power continuously.

Recent improvements in thermoelectric materials, particularly bismuth telluride-based alloys and skutterudites, have raised the efficiency of body-heat harvesting. A team at the Fraunhofer Institute for Integrated Circuits developed a miniaturized TEG measuring just 4 mm by 4 mm that produces 3.5 microwatts at a temperature difference of 2 °C. When coupled with a boost converter and a small storage capacitor, this TEG can power a pacemaker indefinitely under typical indoor conditions.

The main limitation of thermoelectric harvesting is its dependence on ambient temperature. In warm environments where the skin-to-core temperature gradient narrows, power output drops. Modern TEG systems address this by incorporating charge storage buffers that accumulate energy during favorable conditions and release it when the gradient is smaller. For patients living in tropical climates, thermal harvesting alone may not provide enough power, but it can still extend battery life significantly.

Biofuel Cells

Biofuel cells generate electricity by oxidizing biochemical fuels such as glucose using enzymes or microbes as catalysts. The body contains a steady supply of glucose in the bloodstream, making it an attractive fuel source for implantable devices. Enzymatic glucose biofuel cells (GBFCs) use glucose oxidase or similar enzymes at the anode to oxidize glucose, while oxygen from the blood is reduced at the cathode. The net reaction produces water and a small voltage, typically around 0.5 to 0.8 volts per cell.

Recent advances in enzyme immobilization and electrode nanostructuring have improved the power density and longevity of GBFCs. Researchers at the University of Utah reported a glucose biofuel cell that produced 44 microwatts per square centimeter of electrode area, with a half-life of more than 30 days under continuous operation. By stacking multiple cells or increasing the electrode surface area, it is possible to reach the several microwatts needed for pacemaker operation.

However, biofuel cells face significant hurdles before they can be used in patients. Enzymes degrade over time, requiring periodic replacement or encapsulation strategies that maintain activity. The electrodes must be highly selective for glucose to avoid interference from other blood constituents, and the device must not trigger a foreign body response that encapsulates it in fibrous tissue. Despite these challenges, the concept of a pacemaker powered by the patient's own blood glucose remains one of the most elegant visions in energy harvesting.

Triboelectric Nanogenerators

Triboelectric nanogenerators (TENGs) produce electricity through the contact-electrification effect, where two dissimilar materials exchange charge when rubbed together and then separated. In the body, TENGs can be activated by cardiac motion, breathing, or blood flow. The advantage of TENGs is their ability to generate relatively high voltages (tens to hundreds of volts) from small mechanical displacements, which can then be stepped down to useful levels for electronics.

A collaborative team from Georgia Tech and the University of Connecticut developed a TENG only 1 centimeter in diameter that fits on the surface of a pacemaker. When tested in a rat model, the device produced an average power of 3.6 microwatts from heartbeats, enough to drive a pacemaker with a low pacing threshold. The TENG maintained stable output for over 10 million cycles and showed no signs of inflammation on the heart surface after four weeks of implantation.

TENGs are still far from clinical use, but their simplicity and low cost make them attractive for research. The main challenges are ensuring long-term mechanical stability inside the body and preventing electrical leakage through the encapsulation. As materials and packaging technologies mature, TENGs could become a mainstream power source for next-generation pacemakers.

Hybrid Approaches: Combining Batteries and Harvesters

No single energy harvesting technology can yet guarantee uninterrupted pacing power under all conditions a patient may encounter. Hybrid systems that pair a small primary battery with an energy harvester and a storage capacitor provide the reliability needed for life-critical devices while still achieving major gains in longevity. The harvester charges the capacitor during periods of high energy availability, and the capacitor supplies the pacing pulses. The battery acts as a backup, providing power when the harvested energy is insufficient or when the patient requires high-rate pacing.

Hybrid architectures are already appearing in commercial devices. Medtronic and Boston Scientific have introduced pacemakers with wireless telemetry that uses energy harvesting from the interrogation wand to recharge an internal capacitor, reducing battery drain during programming sessions. More advanced prototypes integrate a piezoelectric or thermoelectric harvester directly into the pacemaker housing, with a solid-state backup battery rated for ten years of operation. If the harvester performs as expected, the battery may never be significantly depleted, effectively extending the device life to twenty years or more.

The combination of energy harvesting with low-power electronics and efficient pacing algorithms creates a virtuous cycle. As microcontrollers and application-specific integrated circuits (ASICs) become more power efficient, the minimum energy required for pacing drops, making harvesting more viable. Some modern pacemakers consume as little as 2 microwatts in standby mode, with pacing pulses requiring 5 to 20 microjoules. At these power levels, a well-designed hybrid system can achieve near-perpetual operation.

Clinical Impact and Patient Benefits

The ultimate measure of any new power technology is how it affects patient outcomes. Extended battery life and the potential for self-powered devices translate directly into fewer surgical interventions, reduced complication rates, and lower healthcare costs. Each pacemaker replacement procedure carries a 1 to 3 percent risk of major complications, including pocket infection, lead damage, and hematoma. Eliminating even a single replacement over a patient's lifetime has significant clinical value.

Energy harvesting also opens the door to smaller pacemakers. Leadless pacemakers, which are implanted directly into the right ventricle via a catheter, eliminate the pocket and lead entirely, but their battery size limits them to a lifespan of about eight to twelve years. A leadless pacemaker equipped with a miniature energy harvester could achieve comparable longevity in a much smaller volume, making the procedure less invasive and suitable for a wider range of patients.

Pediatric patients stand to benefit disproportionately from long-lasting pacemaker power. Children who receive pacemakers may need dozens of replacement surgeries over a lifetime, each with increasing technical difficulty due to scar tissue and altered anatomy. A self-sustaining power system that lasts twenty years or more would transform the management of pediatric heart block, reducing the cumulative burden of procedures and allowing children to grow up with fewer interruptions to their lives.

Challenges and Ongoing Research

Despite the remarkable progress in battery and harvesting technologies, several obstacles remain before these innovations become standard in clinical practice. Safety and biocompatibility are paramount. Any new material or device that contacts body tissues must undergo rigorous testing for cytotoxicity, inflammation, and long-term stability. The regulatory pathway for implantable devices is demanding, with the U.S. Food and Drug Administration and European Medicines Agency requiring extensive preclinical and clinical data before approval.

Power management electronics also present a challenge. The output from energy harvesters is often variable and low-voltage, requiring efficient power conditioning circuits that boost the voltage to levels usable by pacemaker electronics. These circuits must themselves consume very little power, often less than one microwatt, and they must operate reliably for decades. Researchers are developing application-specific integrated circuits that integrate rectification, boosting, and storage management on a single chip, achieving end-to-end efficiency above 80 percent.

Another area of active research is device encapsulation. The inside of the human body is a harsh environment for electronics, with high humidity, corrosive ions, and immune cells that attack foreign materials. Hermetic packaging using titanium or ceramic can protect the electronics but adds bulk and stiffness. Flexible encapsulation using multilayer polymer films or atomic-layer-deposited inorganic coatings offers a compromise, providing excellent barrier properties while allowing the device to conform to tissue.

Wireless power transfer is a complementary approach that is also advancing rapidly. While not strictly energy harvesting, wireless charging can extend the life of a pacemaker battery by allowing periodic recharging through the skin. Systems operating at frequencies between 100 kHz and 13.56 MHz can transfer several milliwatts to a receiver deep in the chest with efficiencies above 50 percent. Combined with a small rechargeable battery, wireless charging could effectively eliminate the need for primary battery replacement, though it does require patient compliance with regular charging sessions.

Future Outlook

The convergence of solid-state batteries, energy harvesting, and ultra-low-power electronics is creating a future in which pacemakers are not only more durable but also smarter and less invasive. Within the next decade, hybrid systems that combine a small solid-state backup battery with a piezoelectric or thermoelectric harvester are expected to reach the market, offering device lifetimes of fifteen to twenty years for most patients. In the longer term, fully self-powered pacemakers that require no battery at all may become a reality for a subset of patients with favorable anatomy and activity levels.

Advances in machine learning and sensing are also influencing power system design. Next-generation pacemakers will incorporate sensors for hemodynamic monitoring, arrhythmia prediction, and even remote health assessment. These additional functions require more power, which in turn drives the need for higher-capacity batteries and more efficient harvesters. The interplay between capability and power will continue to shape the direction of research, with each breakthrough in one area enabling progress in the other.

The ultimate goal is a pacemaker that lasts the lifetime of the patient, adapts to their changing physiological needs, and requires no more maintenance than a routine checkup every few years. With the pace of innovation in battery technology and energy harvesting, that goal is closer than ever before.

Conclusion

Pacemaker battery technology and energy harvesting are advancing rapidly, driven by the need to reduce surgical interventions and improve patient quality of life. Solid-state batteries, advanced lithium chemistries, and biocompatible supercapacitors offer substantial increases in energy density and safety. Piezoelectric, thermoelectric, and biofuel harvesting methods promise to supplement or even replace batteries by capturing energy from the body's own physiology. Hybrid approaches that combine the best of both worlds provide the reliability required for life-critical devices while maximizing longevity. As these technologies mature and navigate regulatory pathways, patients with cardiac conditions can look forward to devices that are smaller, safer, and longer-lasting than ever before.

  • Solid-state and lithium carbon monofluoride batteries could double or triple pacemaker longevity.
  • Piezoelectric harvesters convert heartbeat motion into microwatts of continuous power.
  • Thermoelectric generators leverage body heat to charge devices indefinitely.
  • Biofuel cells and triboelectric nanogenerators offer alternative energy sources from glucose and motion.
  • Hybrid battery-harvester systems provide reliability with significantly reduced replacement frequency.
  • Pediatric and leadless pacemaker patients gain the most from extended-life power technologies.

For more information on pacemaker technology and implantable power systems, visit the Mayo Clinic guide to pacemakers, the Nature research article on piezoelectric energy harvesting for cardiac devices, and the ScienceDirect overview of thermoelectric energy harvesting.